Literature DB >> 690005

Metabolic fate of SCE-963, a new broad-spectrum cephalosporin, after parenteral administration in rats and dogs.

S Tanayama, T Kondo, Y Kanai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 690005     DOI： 10.7164/antibiotics.31.703

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  6 in total

1.  Forecasting cephalosporin and monobactam antibiotic half-lives in humans from data collected in laboratory animals.

Authors:  J Mordenti
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

2.  Metabolic fate of [14C]SM-1652, a new antipseudomonal cephalosporin, after parenteral administration to rats.

Authors:  H Imasaki; Y Enjoji; H Matsui; R Kawai; S Kawamura; T Okuda
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

3.  Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy.

Authors:  D Terziivanov; Z Gerova; V Vlahov; A Merdzhanov; D Damjanov
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Nephrotoxicity of cefotiam (CGP 14221/E) in rats and rabbits.

Authors:  E D Wachsmuth
Journal:  Arch Toxicol       Date:  1981-09       Impact factor: 5.153

5.  Metabolic fate of SCE-1365, a new broad-spectrum cephalosporin, after parenteral administration to rats and dogs.

Authors:  S Tanayama; K Yoshida; K Adachi; T Kondo
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

Review 6.  Clinical pharmacokinetics of cefotiam.

Authors:  J M Brogard; F Jehl; B Willemin; A M Lamalle; J F Blickle; H Monteil
Journal:  Clin Pharmacokinet       Date:  1989-09       Impact factor: 6.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.